U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06952296) titled 'Study of the Effectiveness of Dydrogesterone in the Treatment of Endometriosis-related Pain' on April 10.
Brief Summary: The study is an observational, multicenter, prospective, single arm study to evaluate the efficacy of dydrogesterone in endometriosis-related pain (EAP).
Study Start Date: April, 2025
Study Type: OBSERVATIONAL
Condition:
Endometriosis
Intervention:
DRUG: Dydrogesterone
The duration of treatment with dydrogesterone is determined by the physician before inclusion in the study and will last for 6 menstrual cycles ("Cycle" used in the protocol refers to menstrual cycle. 1 cycle is 28 days on average)
Recruitment...